Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Di Fu

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
International Journal of Biological Sciences|August 8, 2024
<i>KMT2D</i> mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axisQing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.
Blood|February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell LymphomaXiang Li, Mengke Liu, Qing Shi, et al.
Signal Transduction and Targeted Therapy|March 18, 2022
Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cellsRui Sun, Pei-Pei Zhang, Xiang-Qin Weng, et al.
Frontiers in Public Health|December 26, 2022
Spatial-temporal clustering of an outbreak of SARS-CoV-2 Delta VOC in Guangzhou, China in 2021Qian Zhang, Meng Zhang, Jianxiong Hu, et al.
Hemasphere|May 8, 2025
Integration of gene mutations in risk prognostication for watch-and-wait follicular lymphoma patients initiating first-line treatmentTian-Yuan Xu, Rong-Ji Mu, Hui-Lai Zhang, et al.
Clinical and Translational Medicine|May 30, 2024
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitorZi-Yang Shi, Ying Fang, Peng-Peng Xu, et al.
Cell Reports|September 6, 2025
DDX3X mutation and Epstein-Barr virus cooperate to induce R-loop-dependent oncogenesisHua-Man Cai, Yu-Ran Qiu, Yun Tan, et al.
Cancer Cell|September 29, 2023
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trialMu-Chen Zhang, Shuang Tian, Di Fu, et al.
Cell Reports. Medicine|March 20, 2025
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathologyYu-Qing Wang, Shuo Wang, Hong-Mei Yi, et al.
Clinical and Translational Medicine|December 19, 2021
Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker studyMu-Chen Zhang, Ying Fang, Peng-Peng Xu, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
International Journal of Biological Sciences|August 8, 2024
<i>KMT2D</i> mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axisQing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.
Blood|February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell LymphomaXiang Li, Mengke Liu, Qing Shi, et al.
Signal Transduction and Targeted Therapy|March 18, 2022
Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cellsRui Sun, Pei-Pei Zhang, Xiang-Qin Weng, et al.
Frontiers in Public Health|December 26, 2022
Spatial-temporal clustering of an outbreak of SARS-CoV-2 Delta VOC in Guangzhou, China in 2021Qian Zhang, Meng Zhang, Jianxiong Hu, et al.
Hemasphere|May 8, 2025
Integration of gene mutations in risk prognostication for watch-and-wait follicular lymphoma patients initiating first-line treatmentTian-Yuan Xu, Rong-Ji Mu, Hui-Lai Zhang, et al.
Clinical and Translational Medicine|May 30, 2024
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitorZi-Yang Shi, Ying Fang, Peng-Peng Xu, et al.
Cell Reports|September 6, 2025
DDX3X mutation and Epstein-Barr virus cooperate to induce R-loop-dependent oncogenesisHua-Man Cai, Yu-Ran Qiu, Yun Tan, et al.
Cancer Cell|September 29, 2023
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trialMu-Chen Zhang, Shuang Tian, Di Fu, et al.
Cell Reports. Medicine|March 20, 2025
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathologyYu-Qing Wang, Shuo Wang, Hong-Mei Yi, et al.
Clinical and Translational Medicine|December 19, 2021
Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker studyMu-Chen Zhang, Ying Fang, Peng-Peng Xu, et al.
Pageof 19